QurCan Therapeutics Inc.
Developer of a nanotechnology-based drug delivery platform intended to provide precision medicine for solid-tumor cancer therapy. The company's platform TERP overcomes the poor drug release and liver accumulation of lipid nanoparticles and efficiently delivers drugs, antibodies and RNA to hard-to-reach tumors, including the brain.
1
Funding Rounds
$3.0m
Money raised
Overview
Developer of a nanotechnology-based drug delivery platform intended to provide precision medicine for solid-tumor cancer therapy. The company's platform TERP overcomes the poor drug release and liver accumulation of lipid nanoparticles and efficiently delivers drugs, antibodies and RNA to hard-to-reach tumors, including the brain.
-
Website:
- Social accounts:
Funding series
Funding Series Analysis
The company QurCan Therapeutics Inc. has raised a total of $3m in funding over 1 rounds.
Key Insights:
- QurCan Therapeutics Inc. Seed round, March 17, 2021: $3m
QurCan Therapeutics Inc. Seed round, March 17, 2021
$3m
Industries
QurCan Therapeutics Inc. is active in the following industries: